stocktools
Offerings // Vivos Therapeutics, Inc.

VVOS offering history

Every offering-related filing in Vivos Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 301 filings back to Sep 28, 2017.

Last executed offering
Oct 19, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Apr 30, 2026
S-3/A — capacity, not a sale
Executed, last 12 months
7
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
Oct 19, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 8, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 7, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 8, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 8, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 8, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 30, 2026S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Apr 3, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 17, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jan 20, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 16, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 14, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 7, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 24, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 12, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 10, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 5, 2025S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Jun 13, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 23, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 14, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 11, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jan 31, 2025424B1 →EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Jan 30, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 29, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jan 22, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Dec 26, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 23, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 20, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 20, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 8, 2024424B1 →EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Aug 7, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 30, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 14, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 26, 2024424B1 →EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Apr 26, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 22, 2024S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 9, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Feb 15, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 1, 2023424B1 →EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Dec 1, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
VVOS offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full VVOS workspace →
VVOS offering FAQ

When did VVOS last execute an offering?

Per SEC filings, Vivos Therapeutics, Inc.'s most recent priced offering document is a 8-K filed 2026-10-19. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did VVOS last announce or register an offering?

The most recent registration is a S-3/A filed 2026-04-30. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.